• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家兔中同时含有载脂蛋白A-I和A-II的高密度脂蛋白的形成。

Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit.

作者信息

Hime Neil J, Drew Kate J, Wee Kevin, Barter Philip J, Rye Kerry-Anne

机构信息

Lipid Research Group, The Heart Research Institute, Camperdown, Sydney, New South Wales 2050, Australia.

出版信息

J Lipid Res. 2006 Jan;47(1):115-22. doi: 10.1194/jlr.M500284-JLR200. Epub 2005 Oct 12.

DOI:10.1194/jlr.M500284-JLR200
PMID:16222033
Abstract

Human plasma HDLs are classified on the basis of apolipoprotein composition into those that contain apolipoprotein A-I (apoA-I) without apoA-II [(A-I)HDL] and those containing apoA-I and apoA-II [(A-I/A-II)HDL]. ApoA-I enters the plasma as a component of discoidal particles, which are remodeled into spherical (A-I)HDL by LCAT. ApoA-II is secreted into the plasma either in the lipid-free form or as a component of discoidal high density lipoproteins containing apoA-II without apoA-I [(A-II)HDL]. As discoidal (A-II)HDL are poor substrates for LCAT, they are not converted into spherical (A-II)HDL. This study investigates the fate of apoA-II when it enters the plasma. Lipid-free apoA-II and apoA-II-containing discoidal reconstituted HDL [(A-II)rHDL] were injected intravenously into New Zealand White rabbits, a species that is deficient in apoA-II. In both cases, the apoA-II was rapidly and quantitatively incorporated into spherical (A-I)HDL to form spherical (A-I/A-II)HDL. These particles were comparable in size and composition to the (A-I/A-II)HDL in human plasma. Injection of lipid-free apoA-II and discoidal (A-II)rHDL was also accompanied by triglyceride enrichment of the endogenous (A-I)HDL and VLDL as well as the newly formed (A-I/A-II)HDL. We conclude that, irrespective of the form in which apoA-II enters the plasma, it is rapidly incorporated into spherical HDLs that also contain apoA-I to form (A-I/A-II)HDL.

摘要

人血浆高密度脂蛋白(HDL)根据载脂蛋白组成可分为含有载脂蛋白A-I(apoA-I)而不含载脂蛋白A-II的(A-I)HDL和含有apoA-I和apoA-II的(A-I/A-II)HDL。ApoA-I作为盘状颗粒的一种成分进入血浆,这些颗粒被卵磷脂胆固醇酰基转移酶(LCAT)重塑为球形(A-I)HDL。ApoA-II以无脂形式或作为不含apoA-I的含apoA-II的盘状高密度脂蛋白((A-II)HDL)的一种成分分泌到血浆中。由于盘状(A-II)HDL是LCAT的不良底物,它们不会转化为球形(A-II)HDL。本研究调查了apoA-II进入血浆后的命运。将无脂apoA-II和含apoA-II的盘状重组HDL((A-II)rHDL)静脉注射到新西兰白兔体内,该物种缺乏apoA-II。在这两种情况下,apoA-II都迅速且定量地掺入球形(A-I)HDL中,形成球形(A-I/A-II)HDL。这些颗粒在大小和组成上与人类血浆中的(A-I/A-II)HDL相当。注射无脂apoA-II和盘状(A-II)rHDL还伴随着内源性(A-I)HDL和极低密度脂蛋白(VLDL)以及新形成的(A-I/A-II)HDL的甘油三酯富集。我们得出结论,无论apoA-II以何种形式进入血浆,它都会迅速掺入也含有apoA-I的球形HDL中,形成(A-I/A-II)HDL。

相似文献

1
Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit.家兔中同时含有载脂蛋白A-I和A-II的高密度脂蛋白的形成。
J Lipid Res. 2006 Jan;47(1):115-22. doi: 10.1194/jlr.M500284-JLR200. Epub 2005 Oct 12.
2
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits.载脂蛋白A-I作为无脂蛋白质或盘状及球状重组高密度脂蛋白成分的代谢:野生型和肝脂肪酶转基因兔的研究
Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1912-7. doi: 10.1161/01.atv.0000038485.94020.7f.
3
Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.包含载脂蛋白A-I和A-II的球形、重组高密度脂蛋白的形成是由卵磷脂胆固醇酰基转移酶介导的。
J Biol Chem. 2000 Mar 24;275(12):9019-25. doi: 10.1074/jbc.275.12.9019.
4
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.载脂蛋白E对重组高密度脂蛋白结构的调控及重塑作用
J Lipid Res. 2006 May;47(5):1025-36. doi: 10.1194/jlr.M500525-JLR200. Epub 2006 Feb 1.
5
Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.载脂蛋白A-II抑制高密度脂蛋白重塑和低脂载脂蛋白A-I的形成。
J Biol Chem. 2003 Jun 20;278(25):22530-6. doi: 10.1074/jbc.M213250200. Epub 2003 Apr 10.
6
Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.载脂蛋白E球形重组高密度脂蛋白经磷脂转运蛋白的重塑
J Lipid Res. 2008 Jan;49(1):115-26. doi: 10.1194/jlr.M700220-JLR200. Epub 2007 Oct 5.
7
Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.重组高密度脂蛋白抑制细胞因子诱导人脐静脉内皮细胞中血管细胞黏附分子-1表达的能力。
J Lipid Res. 1999 Feb;40(2):345-53.
8
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.前β迁移的低脂载脂蛋白A-I的形成与代谢。
Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):421-8. doi: 10.1161/01.ATV.0000104029.74961.f5. Epub 2003 Oct 30.
9
Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.在未酯化脂肪酸和载脂蛋白A-I来源存在的情况下,高密度脂蛋白前体与含载脂蛋白B的脂蛋白解离。
J Lipid Res. 1991 Jun;32(6):917-33.
10
Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.抑制盘状高密度脂蛋白(HDL)向球状HDL转化的天然存在及生物工程改造的载脂蛋白A-I(apoA-I)突变:异常HDL表型可通过卵磷脂胆固醇酰基转移酶(LCAT)治疗得到纠正。
Biochem J. 2007 Aug 15;406(1):167-74. doi: 10.1042/BJ20070296.

引用本文的文献

1
Speciated High-Density Lipoprotein Biogenesis and Functionality.高密度脂蛋白的分类生成与功能
Curr Atheroscler Rep. 2016 May;18(5):25. doi: 10.1007/s11883-016-0572-7.
2
High Density Lipoprotein and it's Dysfunction.高密度脂蛋白及其功能障碍。
Open Biochem J. 2012;6:78-93. doi: 10.2174/1874091X01206010078. Epub 2012 Jul 27.
3
Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.载脂蛋白 A-II 在人高密度脂蛋白(HDL)结构和重塑中的作用:HDL 上的蛋白质构象总体。
Biochemistry. 2012 Jun 12;51(23):4633-41. doi: 10.1021/bi300555d. Epub 2012 Jun 1.
4
Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.载脂蛋白 E 通过体内肝脏低密度脂蛋白受体介导小剂量链球菌血清混浊因子增强血浆高密度脂蛋白胆固醇清除。
Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1834-41. doi: 10.1161/ATVBAHA.111.224360. Epub 2011 May 19.
5
Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.载脂蛋白A-I、A-II和E在人肝癌细胞的细胞内和新分泌的高密度脂蛋白之间独立分布。
Biochim Biophys Acta. 2009 Dec;1791(12):1125-32. doi: 10.1016/j.bbalip.2009.07.004. Epub 2009 Jul 25.
6
Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles.磷脂介导的高密度脂蛋白转化产生特定的载脂蛋白A-II前β迁移率颗粒。
J Lipid Res. 2009 Apr;50(4):667-75. doi: 10.1194/jlr.M800399-JLR200. Epub 2008 Dec 9.
7
Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance.载脂蛋白AII是极低密度脂蛋白代谢和胰岛素抵抗的调节因子。
J Biol Chem. 2008 Apr 25;283(17):11633-44. doi: 10.1074/jbc.M708995200. Epub 2007 Dec 26.